Riverhead Capital Management LLC grew its position in Express Scripts Holding Co (NASDAQ:ESRX) by 12.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 32,719 shares of the company’s stock after purchasing an additional 3,511 shares during the quarter. Riverhead Capital Management LLC’s holdings in Express Scripts were worth $3,109,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hsbc Holdings PLC grew its holdings in Express Scripts by 36.4% in the third quarter. Hsbc Holdings PLC now owns 958,566 shares of the company’s stock worth $91,061,000 after purchasing an additional 255,961 shares during the last quarter. Omni Partners LLP grew its holdings in shares of Express Scripts by 22.0% during the second quarter. Omni Partners LLP now owns 281,026 shares of the company’s stock valued at $21,698,000 after buying an additional 50,664 shares during the last quarter. Marco Investment Management LLC grew its holdings in shares of Express Scripts by 168.2% during the second quarter. Marco Investment Management LLC now owns 79,246 shares of the company’s stock valued at $6,119,000 after buying an additional 49,696 shares during the last quarter. BlackRock Inc. grew its holdings in shares of Express Scripts by 1.5% during the second quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock valued at $2,735,103,000 after buying an additional 538,578 shares during the last quarter. Finally, Commonwealth Bank of Australia grew its holdings in shares of Express Scripts by 15.6% during the second quarter. Commonwealth Bank of Australia now owns 296,858 shares of the company’s stock valued at $22,915,000 after buying an additional 39,983 shares during the last quarter. 85.02% of the stock is currently owned by institutional investors and hedge funds.
In other Express Scripts news, Director Mahon Thomas P. Mac sold 5,234 shares of the company’s stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total value of $520,783.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.79% of the stock is currently owned by corporate insiders.
NASDAQ:ESRX opened at $95.85 on Friday. Express Scripts Holding Co has a one year low of $66.93 and a one year high of $101.73. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.65 and a current ratio of 0.77. The firm has a market capitalization of $55.25 billion, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 1.23 and a beta of 0.88.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 EPS for the quarter, beating the consensus estimate of $2.42 by $0.01. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The company had revenue of $25.56 billion for the quarter, compared to analyst estimates of $25.11 billion. During the same period in the prior year, the company earned $2.51 earnings per share. The firm’s revenue was up 3.6% on a year-over-year basis. Sell-side analysts anticipate that Express Scripts Holding Co will post 9.08 earnings per share for the current year.
A number of brokerages have recently weighed in on ESRX. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Tuesday, September 18th. Royal Bank of Canada boosted their price objective on shares of Express Scripts to $94.00 and gave the company an “outperform” rating in a report on Monday, August 27th. Barclays boosted their price objective on shares of Express Scripts from $83.00 to $90.00 and gave the company an “equal weight” rating in a report on Thursday, November 1st. Maxim Group reissued a “hold” rating on shares of Express Scripts in a report on Thursday, November 1st. Finally, Mizuho set a $101.00 price objective on shares of Express Scripts and gave the company a “hold” rating in a report on Monday, November 5th. One investment analyst has rated the stock with a sell rating, fourteen have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Express Scripts currently has an average rating of “Hold” and an average price target of $92.14.
COPYRIGHT VIOLATION WARNING: “Riverhead Capital Management LLC Has $3.11 Million Holdings in Express Scripts Holding Co (ESRX)” was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://www.thelincolnianonline.com/2018/12/08/riverhead-capital-management-llc-has-3-11-million-holdings-in-express-scripts-holding-co-esrx.html.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
See Also: Ex-Dividend
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.